Sarepta Therapeutics Inc (NASDAQ:SRPT)

143.93
Delayed Data
As of 4:00pm ET
 +38.69 / +36.76%
Today’s Change
32.36
Today|||52-Week Range
176.50
+158.68%
Year-to-Date

Today’s Trading

Previous close105.24
Today’s open160.00
Day’s range135.73 - 176.50
Volume15,344,819
Average volume (3 months)1,375,234
Market cap$6.1B
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)+84.34%
Earnings growth (this year)-147.13%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+2,751.58%
P/E ratioNM
Price/Sales21.17
Price/Book7.64

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-1.64-1.65%
LOXOLoxo Oncology Inc+1.30+0.73%
RAREUltragenyx Pharmaceu...+1.67+2.11%
IRWDIronwood Pharmaceuti...-0.06-0.32%
Data as of 4:00pm ET, 06/19/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$154.6M
Annual profit (last year)-$50.7M
Net profit margin-32.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas S. Ingram
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts